Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Draper

Showing results (361-370 of 404) with videos related to

Pageof 41
Sort By:
Frontiers in Immunology|March 18, 2026
B and T cell responses to pre-erythrocytic R21/Matrix-M and blood-stage RH5.1/Matrix-M malaria vaccines in endemic settingsCaroline K Bundi, Olivia Muñoz, Elizabeth Kibwana, et al.
Frontiers in Immunology|February 1, 2024
Analyses of human vaccine-specific circulating and bone marrow-resident B cell populations reveal benefit of delayed vaccine booster dosing with blood-stage malaria antigensJordan R Barrett, Sarah E Silk, Catherine G Mkindi, et al.
Frontiers in Microbiology|October 30, 2016
Changes in Serological Immunology Measures in UK and Kenyan Adults Post-controlled Human Malaria InfectionSusanne H Hodgson, David Llewellyn, Sarah E Silk, et al.
Malaria Journal|January 29, 2015
Increased sample volume and use of quantitative reverse-transcription PCR can improve prediction of liver-to-blood inoculum size in controlled human malaria infection studiesSusanne H Hodgson, Alexander D Douglas, Nick J Edwards, et al.
Scientific Reports|June 12, 2015
Comparative assessment of transmission-blocking vaccine candidates against Plasmodium falciparumM C Kapulu, D F Da, K Miura, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 27, 2014
Combining viral vectored and protein-in-adjuvant vaccines against the blood-stage malaria antigen AMA1: report on a phase 1a clinical trialSusanne H Hodgson, Prateek Choudhary, Sean C Elias, et al.
JCI Insight|January 24, 2023
Delayed boosting improves human antigen-specific Ig and B cell responses to the RH5.1/AS01B malaria vaccineCarolyn M Nielsen, Jordan R Barrett, Christine Davis, et al.
Nature|September 9, 2021
Positive allosteric mechanisms of adenosine A<sub>1</sub> receptor-mediated analgesiaChristopher J Draper-Joyce, Rebecca Bhola, Jinan Wang, et al.
Frontiers in Cellular and Infection Microbiology|January 6, 2023
RH5.1-CyRPA-Ripr antigen combination vaccine shows little improvement over RH5.1 in a preclinical settingJulie Healer, Jennifer K Thompson, Karen L Mackwell, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 25, 2011
Phase Ia clinical evaluation of the Plasmodium falciparum blood-stage antigen MSP1 in ChAd63 and MVA vaccine vectorsSusanne H Sheehy, Christopher J A Duncan, Sean C Elias, et al.
Pageof 41

Showing results (361-370 of 404) with videos related to

Sort By:
Pageof 41
Frontiers in Immunology|March 18, 2026
B and T cell responses to pre-erythrocytic R21/Matrix-M and blood-stage RH5.1/Matrix-M malaria vaccines in endemic settingsCaroline K Bundi, Olivia Muñoz, Elizabeth Kibwana, et al.
Frontiers in Immunology|February 1, 2024
Analyses of human vaccine-specific circulating and bone marrow-resident B cell populations reveal benefit of delayed vaccine booster dosing with blood-stage malaria antigensJordan R Barrett, Sarah E Silk, Catherine G Mkindi, et al.
Frontiers in Microbiology|October 30, 2016
Changes in Serological Immunology Measures in UK and Kenyan Adults Post-controlled Human Malaria InfectionSusanne H Hodgson, David Llewellyn, Sarah E Silk, et al.
Malaria Journal|January 29, 2015
Increased sample volume and use of quantitative reverse-transcription PCR can improve prediction of liver-to-blood inoculum size in controlled human malaria infection studiesSusanne H Hodgson, Alexander D Douglas, Nick J Edwards, et al.
Scientific Reports|June 12, 2015
Comparative assessment of transmission-blocking vaccine candidates against Plasmodium falciparumM C Kapulu, D F Da, K Miura, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 27, 2014
Combining viral vectored and protein-in-adjuvant vaccines against the blood-stage malaria antigen AMA1: report on a phase 1a clinical trialSusanne H Hodgson, Prateek Choudhary, Sean C Elias, et al.
JCI Insight|January 24, 2023
Delayed boosting improves human antigen-specific Ig and B cell responses to the RH5.1/AS01B malaria vaccineCarolyn M Nielsen, Jordan R Barrett, Christine Davis, et al.
Nature|September 9, 2021
Positive allosteric mechanisms of adenosine A<sub>1</sub> receptor-mediated analgesiaChristopher J Draper-Joyce, Rebecca Bhola, Jinan Wang, et al.
Frontiers in Cellular and Infection Microbiology|January 6, 2023
RH5.1-CyRPA-Ripr antigen combination vaccine shows little improvement over RH5.1 in a preclinical settingJulie Healer, Jennifer K Thompson, Karen L Mackwell, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 25, 2011
Phase Ia clinical evaluation of the Plasmodium falciparum blood-stage antigen MSP1 in ChAd63 and MVA vaccine vectorsSusanne H Sheehy, Christopher J A Duncan, Sean C Elias, et al.
Pageof 41